Interim / Quarterly Report • Nov 13, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
{0}------------------------------------------------

{1}------------------------------------------------

{2}------------------------------------------------

{3}------------------------------------------------
During the quarter, Norcod has harvested a total of 515 tonnes from Jamnungen . All biomass was processed at Norcod's harvesting facility Kråkøy Slakteri.
In Q3, 84% of the harvested volume held superior quality.
During the quarter, the Jamnungen site experienced significant challenges with increased mortality. More information on the following pages.
We have been preparing the Frosvika site for stocking of fish in Q4.
Throughout the summer, we have experienced favourable temperatures for growth, and the Bjørvika site has performed well with strong growth and low mortality.
Production at the Skogsøya and Pålskjæra sites at Mausund is progressing according to plan, with strong growth and low mortality.
Our two new sites, Snyen and Selsøy, are currently being prepared for stocking in 2026.
At the start of Q3, Norcod temporarily paused harvesting to allow the fish to grow and reach an average weight aligned with market demand. This period was also used to upgrade the Kråkøy processing plant, including the installation of a new gutting machine.
We have aligned our future production plan at new and existing locations to have an ideal balance between spring and fall releases, which will ensure a stable 12-month production and harvest in the future. This results in a temporary lower level of biomass at sea but lays the foundation for profitable growth.

{4}------------------------------------------------
During the quarter, Norcod experienced significant mortalities at the Jamnungen site due to Vibrio infection. Investigations confirmed that the incident involved a bacterial strain not covered by the existing vaccine. In close consultation with veterinarians at the Norwegian Food Safety Authority it was decided to treat the affected fish with medicine feed to treat the infection and secure fish welfare. Despite continuous monitoring and prompt and effective treatment, the incidence led to significantly elevated mortality levels.
Norcod's vaccination programme uses autogenous vaccines, enabling adaptation to emerging bacterial strains. The identified Vibrio strain will therefore be included in future vaccine formulations to prevent reoccurrence.
Harvesting at Jamnungen commenced as planned in mid-September. The fish showed excellent quality, with over 90% graded as superior. Total harvest volume from the site for 2025 remains unchanged, while the increased mortality is expected to result in a reduction in the 2026 harvest volume, including a harvesting pause for Q1 2026.

{5}------------------------------------------------
We are progressing according to Norcod's growth plan, having secured two additional sites that will be fully operational in 2026. In addition, a new agreement ensure sufficient juvenile capacity from the land-based phase.

{6}------------------------------------------------

{7}------------------------------------------------

Harvest volume (tonnes WFE)

Revenues (MNOK)

Production cost at sea (NOK per kg WFE)

Available credit and cash at hand (MNOK)

{8}------------------------------------------------




{9}------------------------------------------------
| Q3 - 2025 |
2025 YTD |
Q3 - 2024 |
2024 YTD |
Y/Y-% | 2024 FY |
|
|---|---|---|---|---|---|---|
| Operating revenue |
36 805 |
321 604 |
68 948 |
273 462 |
% 17 6 , |
397 183 |
| cost* Production |
-29 856 |
-294 903 |
-75 535 |
-272 850 |
% -8 1 , |
-382 866 |
| Other operating expenses |
-29 261 |
613 -144 |
-43 692 |
-146 027 |
0 % 1 , |
-208 130 |
| of excl non-recurring items and adjustment biomass EBIT FV |
-22 313 |
913 -117 |
-50 279 |
-145 415 |
18 9 % , |
-193 813 |
| Non-recurring items |
-43 173 |
-45 574 |
-23 024 |
-23 024 |
-28 896 |
|
| of FV-adjustment biomass |
776 | 9 380 |
64 | -832 | 17 740 |
|
| EBIT | -64 710 |
-154 107 |
-73 239 |
-169 271 |
9 0 % , |
-204 969 |
| EBIT-margin | -175 8 % , |
-47 9 % , |
-106 2 % , |
-61 9 % , |
22 6 % , |
-51 6 % , |
| volume Harvest WFE |
515 | 5 985 |
1 348 |
5 943 |
0 7 % , |
8 333 |
| Production per kg* NOK cost |
58 0 , |
49 3 , |
56 0 , |
45 9 , |
7 3 % , |
45 9 , |
* before harvest, wellboat, freight and non-production admin
{10}------------------------------------------------
Operating revenues for the third quarter were 37 MNOK based on a harvested volume of 515 tonnes, down from 69 MNOK and a harvested volume of 1.348 tonnes in Q3-24. Operating expenses ended at 102 MNOK, down from 142 MNOK in Q3-24. The decrease is mainly explained by the lower harvesting volume compared to the corresponding quarter last year, as we only harvested the last three weeks of September.
Production cost per kg had a small increase from 56 NOK per kg WFE in Q3-24 to 58 NOK per kg WFE in Q3-25. The increase is mainly explained by the low harvest volume during the quarter and several additional costs incurred in relation to the incident at Jamnungen.
In addition, we have recorded net losses of 43 MNOK in non-recurring items relating to the extraordinary mortality during the period. This includes a provision for insurance settlements relating to this incident.
Despite this incident we are still cutting the operating losses down to -65 MNOK in Q3-25, from -73 MNOK in Q3-24. Net loss for the period ended at 71 MNOK, down from 82 MNOK in the corresponding quarter last year.
The overall financial performance is developing in a positive direction, as the YTD EBIT-margin is improving by 22,6% year-over-year with a movement from -61,9% in Q3-24 to -47,9% in Q3-25.

{11}------------------------------------------------
Total assets ended at 589 MNOK in Q3-25, down from 624 MNOK in Q3-24. The change from last year is mainly explained by a decrease in biological assets due to the increased mortality and postponed stocking of new fish in order to optimise future growth cycles. In addition, we have sold some rightof-use assets less suitable for our operations.
Available credit at the end of the quarter is 8 MNOK, and together with 20 MNOK in cash at hand the total available funds ended at 28 MNOK, down from 92 MNOK in Q3-24. The additional funding secured in November enables us to proceed with our scale-up plan and stocking of new sites next year even though we have faced some challenges this year.
Total equity ended at 140 MNOK, down from 197 MNOK in Q3-24.
Total non-current liabilities ended at 135 MNOK in Q3-25, down from 145 MNOK in Q3-24 mainly due to a reduction in leasing liabilities resulting from the sale of assets and a disbursement of the first tranche of the term-loan from DNB secured during the first quarter this year.
The current interest-bearing debt ended at 190 MNOK, up from 116 MNOK in Q3-24. Total current liabilities ended at 313 MNOK in Q3-25, up from 281 MNOK in Q3-24. The change is mainly due to a larger utilisation of the overdraft facility compared to the corresponding quarter last year.

{12}------------------------------------------------
Net cash flows from operating activities ended on -74 MNOK in Q3-25, compared to -2 MNOK in Q3-24. The handling of the situation at Jamnungen has demanded significant cashflow and loss of revenue.
The investing activities generated net cash flows of 17 MNOK in Q3-25 as opposed to -12 MNOK in Q3-24. This difference is related to net sale of equipment during this quarter, and less payments for new purchases compared to Q3-24.
Net cash flows from financing activities ended at 68 MNOK in Q3-25, compared to -15 MNOK during Q3-24. This quarter, we have increased the utilisation of the overdraft facilities, received disbursement of a new term-loan and settled all Artha-shareholder loans.

{13}------------------------------------------------

{14}------------------------------------------------
The cod market remains strong, with continued high prices and solid demand across key regions. Snow Cod prices continue to rise in line with a positive trend for farmed cod, supported by strong market development and increasing recognition of quality. Average revenue per kilo of cod sold increased by 31% from September 2024 to September 2025.
Norcod maintains a very high share of superior-grade fish, resulting in premium prices and strong satisfaction among customers.
Norcod's renewed agreement with long-term sales, logistics and marketing partner Sirena Group secures improved terms and a stronger platform for stable, profitable growth.
Market access and positioning continue to advance, with favourable conditions for sustainable, traceable whitefish reinforcing Norcod's premium strategy and long-term growth outlook.
Our shareholder and leading retail and foodservice supplier, High Liner Foods, strengthens distribution and market penetration in North America, while the recent investment from Jerónimo Martins strengthens our direct access to some of Europe's major supermarket chains.

{15}------------------------------------------------

{16}------------------------------------------------
Norcod has entered the next phase of its growth strategy, commencing the planned scaleup towards 25,000 tonnes of annual production. The foundation for growth is firmly in place, with strong biological performance at key sites and the first step in execution beginning in Q4 with stocking at Frosvika.
While Jamnungen experienced weaker biological results this year, operations at all other sites demonstrated solid biological and operational control, confirming that Norcod's farming model and management routines are robust and scalable.
Production volume for 2025 is on track, although a temporary dip is expected in 2026 due to the increased mortality at Jamnungen.
The company's growth trajectory is strengthened by strategic ownership and a unique sales and distribution setup. The addition of Jerónimo Martins as a new key shareholder, investing NOK 157 million, brings both production expertise and direct retail access. Alongside existing partners Sirena Group and High Liner Foods, Norcod now has unmatched access to leading retailers across Europe and the United States.
With some of the best farming locations in Norway, the integrated Kråkøy harvesting plant, and a powerful commercial network, Norcod is well positioned to deliver on its growth strategy and capture the expanding market for premium farmed cod.

{17}------------------------------------------------
The investment by Jerónimo Martins represents a strategic partnership that strengthens Norcod's capital base and market reach.
Through a NOK 157 million equity investment, Jerónimo Martins now holds an 18.06 percent ownership stake in Norcod.
Headquartered in Portugal, Jerónimo Martins is a leading international food group with more than 230 years of experience in food retail and distribution.
As the 25th largest food retailer globally, the group operates 6,000+ stores across six countries and employs nearly 140,000 people. Its major retail chains include Biedronka in Poland, Pingo Doce in Portugal and Ara in Colombia.
The partnership gives Norcod a strong, long-term owner with existing investments in both sea-based and land-based aquaculture, as well as direct access to a broad segment of European retail.
Together with Sirena Group and High Liner Foods, Jerónimo Martins adds powerful market access and retail insight, creating a unique platform for the international growth of Snow Cod.
Revenue 2024: €33.5 bn Net profit 2024: €599 m

World's 25th largest food retailer:

{18}------------------------------------------------

{19}------------------------------------------------

| (Amounts '000) in NOK |
Note | Q3 - 2025 |
YTD 2025 |
Q3 - 2024 |
YTD 2024 |
FY 2024 |
|---|---|---|---|---|---|---|
| Operating revenue |
36 805 |
321 604 |
68 948 |
273 462 |
397 183 |
|
| of materials Cost |
47 347 |
295 619 |
84 112 |
266 334 |
373 036 |
|
| Salaries and personnel |
17 724 |
55 955 |
23 664 |
65 087 |
88 821 |
|
| expenses and Depreciation , amortization impairment |
10 063 |
29 701 |
8 877 |
27 092 |
36 550 |
|
| Other operating expenses |
27 157 |
103 816 |
25 598 |
83 387 |
121 485 |
|
| Operating expenses |
102 291 |
485 090 |
142 251 |
441 901 |
619 892 |
|
| profit/ loss(-) before fair value adj . of biomass Operating |
-65 486 |
-163 487 |
-73 303 |
-168 439 |
-222 709 |
|
| value biomass Fair adjustment |
1 | 776 | 9 380 |
64 | -832 | 740 17 |
| profit/loss Operating |
-64 710 |
-154 107 |
-73 239 |
-169 271 |
-204 969 |
|
| profit/ loss(-) Share of from associates |
0 | 0 | 0 | 0 | 0 | |
| financial Net items |
4 | -6 783 |
-19 196 |
-8 812 |
-25 042 |
-30 033 |
| Profit/loss before tax |
-71 493 |
-173 303 |
-82 051 |
-194 313 |
-235 003 |
|
| Income tax expenses |
0 | 0 | 0 | 0 | 0 | |
| profit/loss for the period Net |
-71 493 |
-173 303 |
-82 051 |
-194 313 |
-235 003 |
|
| Other comprehensive income |
0 | 0 | 0 | 0 | 0 | |
| Total comprehensive income for the period |
-71 493 |
-173 303 |
-82 051 |
-194 313 |
-235 003 |
{20}------------------------------------------------

| (Amounts '000) in NOK |
Note | Q3 - 2025 |
Q3 - 2024 |
2024 |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets |
||||
| licenses , trademarks and similar rights Concessions , patents, |
2 | 2 000 |
2 000 |
2 000 |
| Goodwill | 870 | 0 | 0 | |
| , plant & equipment Property |
142 070 |
145 520 |
145 933 |
|
| Right-of-use assets |
159 886 |
193 716 |
193 127 |
|
| Other investments |
3 | 3 | 3 | 3 |
| Total non-current assets |
304 829 |
341 239 |
341 064 |
|
| Current | ||||
| assets Inventories |
1 | 16 747 |
7 480 |
13 242 |
| Biological assets |
1 | 197 832 |
248 356 |
264 423 |
| Short-term receivables |
48 838 |
17 754 |
32 715 |
|
| Cash and cash equivalents |
20 385 |
8 788 |
22 533 |
|
| Total current assets |
283 803 |
282 377 |
332 914 |
|
| TOTAL ASSETS |
588 632 |
623 616 |
673 978 |
{21}------------------------------------------------

| (Amounts '000) in NOK |
Note | Q3 - 2025 |
Q3 - 2024 |
2024 |
|---|---|---|---|---|
| EQUITY LIABILITIES AND |
||||
| Equity | ||||
| Share capital |
28 830 |
21 902 |
21 902 |
|
| Shares Treasury |
-3 707 |
-3 707 |
-3 707 |
|
| Share premium |
1 155 340 |
1 005 143 |
1 005 143 |
|
| Retained earnings |
-1 040 549 |
-826 556 |
-867 246 |
|
| Total equity |
139 914 |
196 782 |
156 092 |
|
| Liabilities | ||||
| interest-bearing debt Non-current |
4 | 49 172 |
30 507 |
17 018 |
| liabilities Lease |
4 | 86 292 |
114 882 |
111 156 |
| Total liabilities non-current |
135 463 |
145 389 |
128 174 |
|
| leasing Liabilities Current |
31 309 |
34 073 |
34 661 |
|
| Current interest-bearing debt |
190 018 |
116 397 |
205 270 |
|
| Trade payables |
74 923 |
118 569 |
119 981 |
|
| Other liabilities current |
17 006 |
12 406 |
29 799 |
|
| Total liabilities current |
313 255 |
281 446 |
389 711 |
|
| TOTAL EQUITY AND LIABILITIES |
588 632 |
623 616 |
673 978 |
{22}------------------------------------------------

| (Amounts '000) in NOK |
Paid-in equity |
Other equity |
|||||
|---|---|---|---|---|---|---|---|
| 2024 | Share capital |
shares Treasury |
Share premium |
Retained earnings |
Total equity |
||
| Equity as of 1 Jan 2024 |
14 714 |
-3 707 |
846 042 |
-632 242 |
224 806 |
||
| of shares Issue 11 03 2024 |
773 | 17 184 |
17 957 |
||||
| of shares Issue 20 03 2024 |
6 310 |
140 246 |
146 556 |
||||
| of shares Issue 15 04 2024 |
105 | 1 671 |
1 776 |
||||
| profit/loss for the Net year |
-235 003 |
-235 003 |
|||||
| Equity of 31 Dec 2024 as |
21 902 |
-3 707 |
1 005 143 |
-867 246 |
156 092 |
| Retained | |||||
|---|---|---|---|---|---|
| 2025 | Share capital |
shares Treasury |
Share premium |
earnings | Total equity |
| Equity as of 1 Jan 2025 |
21 902 |
-3 707 |
1 005 143 |
-867 246 |
156 092 |
| of shares Issue 24 03 2025 |
6 862 |
149 122 |
155 984 |
||
| of shares Issue 16 04 2025 |
66 | 1 075 |
1 141 |
||
| profit/loss for the Net year |
-173 303 |
-173 303 |
|||
| Equity of 30 Sep 2025 as |
28 830 |
-3 707 |
1 155 340 |
-1 040 549 |
139 914 |
{23}------------------------------------------------

| (Amounts in NOK '000) | Note | Q3 - 2025 |
YTD 2025 |
Q3 - 2024 |
YTD 2024 |
FY 2024 |
|---|---|---|---|---|---|---|
| Profit/loss before tax |
-71 493 |
-173 303 |
-82 051 |
-194 313 |
-235 003 |
|
| paid Taxes |
0 | 0 | 0 | 0 | 0 | |
| Cash flow from operating activities |
0 | |||||
| and Depreciation amortization |
10 063 |
29 701 |
8 877 |
27 092 |
36 550 |
|
| Impairment of intangible assets |
3 | 0 | 0 | 0 | 502 | 502 |
| Gains/losses on sale of non-current assets |
1 761 |
1 761 |
0 | 0 | 0 | |
| Change and biological in inventory assets |
1 | -26 317 |
72 466 |
6 057 |
23 478 |
20 220 |
| value adjustment Fair |
1 | -776 | -9 380 |
-64 | 832 | -17 740 |
| Change receivable in accounts |
-5 914 |
-5 651 |
16 502 |
16 684 |
15 685 |
|
| Change payable in accounts |
28 659 |
-45 058 |
30 082 |
-17 294 |
-15 882 |
|
| Change other receivables and other liabilities in current current |
-9 841 |
-19 292 |
18 446 |
8 165 |
9 557 |
|
| cash flow from Net operating activities |
-73 858 |
-148 757 |
-2 151 |
-134 853 |
-186 111 |
|
| Cash flows from investing activities |
||||||
| for purchase of plant & equipment Payments property, |
065 -5 |
-10 858 |
843 -11 |
-13 885 |
336 -15 |
|
| Proceeds from sale of plant & equipment property, |
21 825 |
21 825 |
0 | 4 228 |
4 228 |
|
| for goodwill Payments |
0 | -870 | 0 | 0 | 0 | |
| cash flow from Net investing activities |
16 760 |
10 098 |
-11 843 |
-9 657 |
-11 107 |
|
| Cash flows from financing activities |
||||||
| from debt Receipts new non-current |
48 000 |
48 000 |
0 | 0 | 3 500 |
|
| overdraft change in bank Net |
71 427 |
1 961 |
-4 329 |
-2 959 |
68 701 |
|
| of debt Repayment |
-31 983 |
-33 059 |
-344 | -1 117 |
-1 461 |
|
| of lease liability Repayment |
-18 541 |
-33 057 |
200 -7 |
216 -17 |
-24 732 |
|
| paid Interest |
2 | -1 321 |
-4 457 |
-3 521 |
-10 476 |
-11 322 |
| Proceeds from issues of shares |
0 | 157 125 |
0 | 166 289 |
166 289 |
|
| cash flow from financing activities Net |
67 583 |
136 511 |
395 -15 |
134 521 |
200 975 |
|
| (decrease)/increase cash cash equivalents Net in and |
10 484 |
-2 149 |
-29 389 |
-9 989 |
3 757 |
|
| Cash and cash equivalents the beginning of the period at |
9 900 |
22 533 |
38 177 |
18 777 |
18 777 |
|
| Cash and cash equivalents close of the period at |
20 385 |
20 385 |
8 788 |
8 788 |
22 533 |
{24}------------------------------------------------

Norcod (the Group) consists of Norcod AS, Norcod Equipment AS, Kråkøy Norcod AS, Kråkøy Norcod Eiendom AS and Norway Royal Cod AS. The Groups head office is located at Thomas Angells gate 22 in Trondheim, Norway. Norcod AS is listed on the Oslo Stock Exchange Euronext Growth under the ticker NCOD.
The condensed, consolidated interim financial statements have been drawn up in accordance with International Financial Reporting Standards (IFRS), including the International Accounting Standards 34 (IAS34) for interim financial reporting and are authorized for issue by the board of directors on 12 Nov 2025. The Group's accounting principles and calculation methods used in the most recent annual accounts are described in the annual report for 2024. No accounting principles have been changed or other standards have been adopted during the period. The annual report is published on www.norcod.no.
The condensed consolidated interim financial statements have not been audited. As a result of rounding differences, numbers or percentages may not add up to the total.
All figures in the notes are in NOK 1 000, unless otherwise specified.
{25}------------------------------------------------

| 30.09.2025 | 30.06.2025 | 30.09.2024 | 31.12.2024 | ||||
|---|---|---|---|---|---|---|---|
| Book value of inventories |
|||||||
| Feed and other materials |
16 747 |
11 384 |
7 480 |
13 242 |
|||
| Total inventories |
16 747 |
11 384 |
7 480 |
13 242 |
|||
| of Book value biological assets |
|||||||
| and cod fry Roe at cost |
38 702 |
20 639 |
21 288 |
17 878 |
|||
| Biological held sea farms assets at at cost |
254 240 |
251 349 |
350 129 |
351 035 |
|||
| Total Biological before fair value adjustment assets |
292 942 |
271 988 |
371 418 |
368 913 |
|||
| value adjustment of biological Fair assets |
-95 110 |
-95 886 |
-123 062 |
-104 490 |
|||
| Total biological assets |
197 832 |
176 102 |
248 356 |
264 423 |
|||
| Q3 - 2025 |
Q2 - 2025 |
YTD 2025 |
Q3 - 2024 |
YTD 2024 |
FY 2024 |
||
| Reconciliation of changes in carrying of biological amount assets |
of comprehensive income Statement post |
||||||
| Opening balance biological assets |
176 102 |
178 818 |
264 423 |
251 865 |
272 052 |
272 052 |
|
| resulting from the Increase production in period |
of materials Cost |
93 984 |
91 624 |
264 506 |
94 986 |
273 009 |
386 393 |
| Reduction due extraordinary mortality to |
-43 173 |
0 | -45 574 |
-23 024 |
-23 024 |
-28 896 |
|
| value adjustment of biomass Fair |
value adjustment biomass Fair |
776 | -2 063 |
9 380 |
64 | -832 | 17 740 |
| Reduction due harvesting the period in to |
-29 856 |
-92 277 |
-294 903 |
-75 535 |
-272 850 |
-382 866 |
|
| Closing balance biological assets |
197 832 |
176 102 |
197 832 |
248 356 |
248 356 |
264 423 |
|
| Volumes of biological sea (1 kg) in 000 assets |
|||||||
| balance biological Opening in assets sea |
3 716 |
4 013 |
6 746 |
7 080 |
7 817 |
7 817 |
|
| Closing balance biological in assets sea |
3 801 |
3 716 |
3 801 |
7 083 |
7 083 |
6 746 |
The group had no uninvoiced finished goods in Q3 2025.
{26}------------------------------------------------

Biological assets are, in accordance with IAS 41 Agriculture, measured at fair value in accordance with IFRS 13. Biomass measured at fair value, is categorized at Level 3 in the fair value hierarchy, as the input is mostly unobservable. All cod at sea are subject to a fair value calculation, while roe and cod fry are measured at cost as cost is deemed a reasonable approximation for fair value as there is little biological transformation.
The technical model used to calculate the fair value of biomass is a present value model. Present value is calculated on the basis of estimated revenues less production costs remaining until the cod is harvestable at the individual site. The cod is harvestable when it has reached the estimated weight required for harvesting specified in the company's budgets and plans. The estimated value is discounted to present value on the date of reporting. The expected biomass at harvest is calculated on the basis of the number of individuals held at sea farms on date of reporting, adjusted for expected mortality up until the point of harvest and multiplied by the fish's estimated weight at harvest. The price is calculated using the Group's best estimate of future prices and are not observable. The price includes the Group's best estimate of the future prices of cod liver and other products of the cod that will be sold. Prices are adjusted for expected costs related to harvesting, sales and carriage costs. The Group applies a monthly discount rate of 2 %.
Estimated remaining production costs are estimated costs that a market participant would presume necessary for the farming of fish up until they reach a harvestable weight. In the model, instead of being a separate cost element in the calculation, compensation for estimated license fees and site leasing costs is included in the discount factor, and thereby reduces the fair value of the biomass.
The fair value of the biomass is calculated using a monthly discounting of the cash flow based on an expected harvesting month according to the harvesting plan. The discount factor is intended to reflect three main components:
The discount factor is set on the basis of an average for all the Group's sites and which, in the Group's assessment, provides a sensible growth curve for the fish – from cod fry to harvestable fish.
The risk adjustment must take account of the risk involved in investing in live fish. Currently the Group expects a cod to spend on average 16-18 months at a sea farm, and the risk will be higher the longer the time until harvest. Biological risk, the risk of increased costs and price risk will be the most important elements to be recognized. The present value model includes a theoretical compensation for license fees and site leasing costs as a surplus to the discount factor in the model, instead of being a cost-reducing factor in the calculation.
{27}------------------------------------------------

| Q3 - 2025 |
YTD 2025 |
Q3 - 2024 |
YTD 2024 |
FY 2024 |
|
|---|---|---|---|---|---|
| Financial income |
|||||
| Other financial income |
108 | 1 130 |
68 | 1 206 |
1 240 |
| Total financial income |
108 | 1 130 |
68 | 1 206 |
1 240 |
| Financial expenses |
|||||
| of financial Impairment assets |
0 | 0 | 0 | 502 | 502 |
| on long loans from credit Interest institutions term |
4 854 |
10 811 |
3 651 |
10 170 |
12 872 |
| Interest expenses leasing |
1 336 |
4 473 |
3 521 |
10 476 |
11 032 |
| Adjustments due currency loss to |
196 | 686 1 |
084 1 |
2 023 |
2 147 |
| Other financial expenses |
504 | 3 357 |
623 | 3 079 |
4 721 |
| Total financial expenses |
6 890 |
20 327 |
8 880 |
26 248 |
31 274 |
| financial items Net |
-6 783 |
-19 196 |
-8 812 |
-25 042 |
-30 033 |
As of 30.09.2025, Norcod does not hold any investments in associated companies.
{28}------------------------------------------------

As of 30 September 2025, the Group has recognised goodwill of TNOK 870, arising from the acquisition of subsidiary, Norway Royal Cod AS, completed during the second quarter of 2025.
The goodwill represents the excess of the consideration transferred over the fair value of the identifiable net assets acquired. The acquisition has been accounted for using the purchase method in accordance with IFRS 3 – Business Combinations.
The allocation of the purchase price is considered provisional and may be adjusted within the 12-month measurement period, as permitted by IFRS 3.
Goodwill is not amortised but is tested for impairment at least annually or more frequently if there are indicators of impairment, in accordance with IAS 36 – Impairment of Assets.
As at 30 September 2025, no impairment indicators have been identified.
The Group will perform its annual impairment test in the fourth quarter.
| (TNOK) Goodwill recognised |
870 |
|---|---|
| value of identifiable acquired (TNOK) Fair net assets |
-112 |
| Consideration transferred (TNOK) |
982 |
{29}------------------------------------------------

| 30.09.2025 | 30.09.2024 | 31.12.2024 | |
|---|---|---|---|
| Non-Current interest-bearing liabilities |
|||
| interest-bearing debt Non-current |
49 172 |
30 507 |
17 018 |
| for right-of-use liabilities Non current assets |
86 292 |
882 114 |
156 111 |
| leasing liabilities Non-current |
135 463 |
145 389 |
128 174 |
| interest-bearing debt: Current |
|||
| liabilities for right-of-use Current assets |
31 309 |
34 073 |
34 661 |
| interest-bearing debt Current |
190 018 |
116 397 |
205 270 |
| Total interest-bearing debt current |
221 326 |
150 470 |
239 931 |
| Total interest-bearing debt |
356 790 |
295 859 |
368 105 |
| Cash and bank deposits |
20 385 |
8 788 |
22 533 |
| interest-bearing debt Net |
336 405 |
287 071 |
345 572 |
{30}------------------------------------------------

DEVOTED TO
PEOPLE · COD · NATURE
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.